Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+3.62%
-2.90%
+0.46%
-1.28%
PFE
Pfizer
$23.76
Login to display Pfizer (PFE) recommendation from the last 90 days from financial news and social media. Strengths
Earnings are forecast to grow
Trading below its fair value
Investors confidence is positive
Pays a reliable dividend
Chart
$24.98 (-4.88%)
$25.24 (-5.86%)
$22.85 (+3.98%)
$29.16 (-18.52%)
PFE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
PFE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Pays a reliable dividend
Future
Future
Earnings are forecast to grow
Trading below its fair value
PFE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PFE Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayPFE Earnings
The TTM reflects 12-month period, providing review of PFE financial performance.
The company financial health has moderately improved over the past year
Financial Score
NVS
123.65
+1.15%
SNY
45.54
+1.04%
MRK
78.56
+1.24%
LLY
724.54
+1.39%
ABBV
220.61
+0.95%
What is PFE current stock price?
What are PFE stock strengths?
What risks are associated with PFE stock?
When is PFE next earnings report?
What is PFE market cap and volume?
What is PFE's current Stock IQ?
Should I buy PFE stock right now?
Is PFE a Strong Buy right now?
What does a 'Strong Buy' rating mean for PFE?
What does a 'Strong Sell' rating mean for PFE?
What factors influence PFE's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.62%
-2.90%
+0.46%
-1.28%
PFE
Pfizer
Current Price
$23.76
Stock Insights
Strengths
Earnings are forecast to grow
Trading below its fair value
Investors confidence is positive
Pays a reliable dividend
Linked to PFE
NVS
123.65
+1.15%
SNY
45.54
+1.04%
MRK
78.56
+1.24%
LLY
724.54
+1.39%
ABBV
220.61
+0.95%
Login to view Pfizer (PFE) recommendation from the last 90 days from financial news and social media.
Chart
$24.98 (-4.88%)
$25.24 (-5.86%)
$22.85 (+3.98%)
$29.16 (-18.52%)
PFE Analysts Opinion
PFE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Pays a reliable dividend
Future
Future
Earnings are forecast to grow
Trading below its fair value
PFE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PFE Street view is extremely bullish and have positive views on the near-term outlook
PFE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayPFE Earnings
The TTM data reflects the most recent 12-month period, providing overview of PFE financial performance.
PFE Financial Health
The company financial health has moderately improved over the past year
Financial Score
PFE Latest Analysis
Pfizer Faces Court Over Depo-Provera Brain Tumor Claims. ) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors with a key court hearing set for late September that could determine whether affected women can .The multidistrict litigation (MDL) consolidated in Florida was launched on behalf of women who developed intracranial meningiomas after using Depo-Provera.Plaintiffs argue the company failed to provide adequate warnings a
Today
Pfizer (PFE) Doubles Down on Obesity Market—But Will It Pay Off?. Pfizer Inc. (NYSE:PFE) is one of the best value stocks in Goldman Sachs portfolio. The company appears to have seized an opportunity that may help it strengthen its portfolio with newer therapies in the face of looming patent expiries for some of its key drugs which could reduce revenue by $15 billion by the end of this [….]
Today
Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock?. Key PointsPfizer is paying over $7 billion to buy clinical-stage biotech Metsera.
Today
Jim Cramer Discusses Sentiment Surrounding Pfizer (PFE). We recently published 14 Stocks Jim Cramer Discussed Including His 2 Top Quantum Computing Stocks. Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently discussed. Pfizer Inc. (NYSE:PFE)s shares are down by 10% year-to-date. In this appearance Cramer discussed the firms $43 billion acquisition of drug company Seagen. Cramer has commented on the [….]
Today
Pfizer (PFE) Dips More Than Broader Market: What You Should Know. In the closing of the recent trading day Pfizer (PFE) stood at $23.6 denoting a -2.03% move from the preceding trading day.
Thu Sep 25, 2025
Does This Acquisition Make Pfizer Stock a Great Buy?. Key PointsObesity is a growing problem that now has effective treatments.
Thu Sep 25, 2025
Dividend Stock Portfolio for Retirement: Pfizers (PFE) Reliable Payouts.
Wed Sep 24, 2025
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?. Key PointsPfizer is a pharmaceutical giant with a huge 7.1% dividend yield.
Wed Sep 24, 2025
Can PFE Successfully Return to the Obesity Space With Metsera Buyout?. Pfizer strikes a $4.9B deal for Metsera adding obesity drug candidates to its pipeline after scrapping danuglipron.
Tue Sep 23, 2025
Whats Pfizer Getting in Its $7.3 Billion Metsera Buyout?. Key PointsPfizer will acquire Metsera in a deal worth $4.9 billion up front and up to $7.3 billion if the acquired assets succeed further.
Tue Sep 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings